Diagnostik und Therapie benigner und prämaligner Veränderungen der
                    Vulva und der Zervix

Literatur
1 Khan MJ, Castle PE, Lorincz AT et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Nat Cancer Inst 2005; 97: 1072-1079
2 von Krogh G. Management of anogenital warts (condylomata acuminata). Eur J Dermatol 2001; 11: 598-603 quiz 4
3 Winer RL, Hughes JP, Feng Q et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006; 354: 2645-2654
4 Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12: 186-192
5 Klug SJ, Hukelmann M, Hollwitz B et al. Prevalence of human papillomavirus types in women screened by cytology in Germany. J Med Virol 2007; 79: 616-625
6 Moscicki AB, Shiboski S, Hills NK et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 2004; 364: 1678-1683
7 von Knebel Doeberitz M, Reuschenbach M, Schmidt D. Biomarkers for cervical cancer screening: the role of p 16(INK4a) to highlight transforming HPV infections. Expert Rev Proteomics 2012; 9: 149-163
8 Griesser H, Sander H, Walczak C. HPV vaccine protein L1 predicts disease outcome of high-risk HPV+ early squamous dysplastic lesions. Am J Clin Pathol 2009; 132: 840-845
9 Griesser H, Sander H, Hilfrich R et al. Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild/moderate dysplasia. Anal Quant Cytol Histol 2004; 26: 241-245
10 Kreimer AR, Guido RS, Solomon D et al. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease. Cancer Epidemiol Biomarkers Prev 2006; 15: 908-914
11 Reich O, Lahousen M, Pickel H et al. Cervical intraepithelial neoplasia III: long-term follow-up after cold-knife conization with involved margins. Obstet Gynecol 2002; 99: 193-196
12 Soutter WP, Haidopoulos D, Gornall RJ et al. Is conservative treatment for adenocarcinoma in situ of the cervix safe?. Br J Obstet Gynaecol 2001; 108: 1184-1189
13 Lynch PJ, Moyal-Barracco M, Scurry J. 2011 ISSVD Terminology and classification of vulvar dermatological disorders: an approach to clinical diagnosis. J Lower Genital Tract Dis 2012; 16: 339-344
14 Hampl M, Sarajuuri H, Wentzensen N et al. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol 2006; 108: 1361-1368
15 van Seters M, van Beurden M, de Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol 2005; 97: 645-651